About this episode

This episode discusses the frequency of routine laboratory monitoring in rheumatoid arthritis as highlighted by Bryant England at ACR Convergence 2025.

Ever wonder how often you really need to check "monitoring" labs? If so then this is the podcast for you! Bryant England mentioned this during his excellent Year in Review session at ACR Convergence 2025. I've been meaning to cover it and finally got around to doing so. Have a listen and share with friends! Paper: https://pubmed.ncbi.nlm.nih.gov/40854212/

More episodes of The Evidence Based Rheumatology Podcast

• E134: Brepocitinib in Dermatomyositis (VALOR) · April 17, 2026 · 15 min
• E133: Obinutuzumab for SLE (ALLEGORY) · March 19, 2026 · 15 min
• E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE) · March 5, 2026 · 14 min
• E131: A Sham-Controlled Sham of a Trial: RESET-RA · January 21, 2026 · 15 min
• E130: Telitacicept for SLE · December 22, 2025 · 13 min
• E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD) · November 12, 2025 · 19 min

Explore listener stats, chart rankings, contacts and more on the The Evidence Based Rheumatology Podcast podcast page.